Developments at CBD COP 16
A few weeks before COP29, the Convention on Biological Diversity (CBD) COP16 took place in Cali, Colombia in October. This was the first biodiversity COP since the landmark Kunming-Montreal Global Biodiversity Framework (GBF) was agreed in 2022 and the largest such event in the history of CBD.
Amongst a plethora of report launches and corporate announcements, two stand out as particularly noteworthy from a private sector perspective. Firstly, it was announced that 502 organisations globally – including KPMG - have committed to adopting Taskforce on Nature Related Financial Disclosures (TNFD) aligned risk management and corporate reporting.
Furthermore, three companies (Kering, Holcim and GSK) have set and had approved Science Based Targets for Nature - for land and freshwater - for the first time. This is an important milestone as setting science-based targets for nature is a vital step for companies to support the delivery of the GBF goals.
Although COP16 negotiations were suspended before the summit’s end without adopting a final strategy to scale up finance for biodiversity[1], some modest financial commitments to support the GBF Fund alongside the “Cali Fund” were made.
These commitments will see a portion of revenues generated by companies who utilise digitally sequenced information from nature being paid into a dedicated fund, of which half is delegated to Indigenous Peoples and local communities.
However, continued challenges to close the nature finance gap and increase accountability risk delaying the implementation of the GBF and further exacerbate the task of halting and reversing nature loss in the coming decades.